Designing enzymes for new-to-nature chemistry and non-natural substrates with AlphaProtein Novo
DeepMind's AlphaProtein Novo designs novel enzymes from scratch that outperform natural ones in breaking down toxins and creating drug intermediates.
Deep dive
- AP Novo utilizes generative diffusion models and AlphaFold 3 predictions.
- Successfully created enzymes for 'new-to-nature' chemistry tasks.
- Achieved state-of-the-art efficiency on model reactions compared to traditional methods.
- Demonstrates that de novo design can outperform natural enzyme mining.
- Potential applications include advanced manufacturing, medicine, and environmental remediation.
Decoder
- De novo design: Creating a biological molecule (like a protein) from scratch rather than modifying existing molecules found in nature.
- Pharmacophore: A part of a molecular structure responsible for a particular biological or pharmacological interaction.
Original article
Designing enzymes for new-to-nature chemistry and non-natural substrates with AlphaProtein Novo
Abstract
Creating highly active enzymes for arbitrary reactions is a transformative goal for the molecular sciences. Traditional protein engineering is constrained by a reliance on existing natural starting points, which are often challenging to discover. De novo design offers the potential to overcome this by creating enzymes from first principles, but has yet to achieve practically relevant catalytic properties. Here we present AlphaProtein Novo (AP Novo), a machine-learning pipeline that demonstrates, for the first time, that de novo enzyme design can outperform natural sequence mining in addressing challenging chemistry. We used AP Novo to design new-to-nature nitrene transferases to synthesise the pharmacophore piperidine with unprecedented product selectivity, and to create enzymes that degrade the environmental toxin DEHP under conditions that denature natural enzymes. We also obtained state-of-the-art catalytic efficiencies on two well-studied model reactions, and through iterative design and analysis found that key enablers of success were mechanism-inspired metrics based on AlphaFold 3 predictions and sequence-ensemble-based scoring of designed backbones. Our results show that de novo design has become a powerful complement to natural enzyme diversity for discovering catalysts for a range of applications.
Competing Interest Statement
Author-affiliated entities have filed a US provisional patent application relating to the de novo design of proteins and enzymes using generative diffusion models and structure prediction neural networks. All of the authors other than Z.-Q.L., M.D., A.N.M., J.C.R., Y.Z., P.L. and F.H.A. have commercial interests in the work described.
Fresh dev news, AI-digested daily. Never miss a trend at devoured.fyi